Yervoi Ipilimumab 50mg / 10ml Injection

50mg / 10ml Injection , Vial

4.5 (154)

₹16,850

Ipilimumab 50mg Injection contains ipilimumab, a monoclonal antibody used as immunotherapy for certain cancers, particularly advanced or metastatic melanoma. It works by blocking CTLA-4, an immune checkpoint protein that normally limits T-cell activity. By inhibiting CTLA-4, Yervoi helps activate the immune system to recognize and attack cancer cells. It may be used alone or in combination with other immunotherapies, depending on the treatment plan. Yervoi can provide durable cancer control in some patients, but requires careful medical monitoring for immune-related side effects during treatment.

Description

Introduction Of Ipilimumab 50mg Injection:

Ipilimumab 50mg Injection is an immune checkpoint inhibitor used mainly in the treatment of advanced or metastatic melanoma, and in certain other cancers including renal cell carcinoma and non-small cell lung cancer.

Ipilimumab 50mg Injection is administered only by a trained healthcare professional as an intravenous infusion, usually over 90 minutes. Your doctor will decide the dose and schedule, often given once every 3 weeks for a set number of doses, based on your condition and treatment plan. It should never be self-administered.

Because this medicine works by activating the immune system, it can sometimes cause the immune system to attack healthy tissues as well. Diarrhea, skin rash, and fatigue are among the most common effects. Your doctor will monitor you closely for signs of inflammation in the intestines, liver, skin, or hormone glands. Inform your doctor immediately if you notice severe abdominal pain, persistent diarrhea, yellowing of the skin or eyes, or unusual fatigue.

Uses Of Ipilimumab 50mg Injection:

  • Advanced/Metastatic Melanoma
  • Advanced Renal Cell Carcinoma
  • Certain other advanced cancers (in combination regimens), including lung and colorectal cancer

Benefits Of Ipilimumab 50mg Injection:

1. Advanced Melanoma

Melanoma is a serious form of skin cancer that can spread to other parts of the body. Ipilimumab 50mg Injection works by releasing a natural brake on the immune system, allowing T-cells to recognize and attack melanoma cells more effectively, which can improve survival in advanced disease.

2. Advanced Renal Cell Carcinoma and Other Cancers

In advanced kidney cancer and certain other cancers, Ipilimumab 50mg Injection, often combined with other immunotherapy drugs, helps stimulate a stronger immune response against tumor cells, supporting disease control.

Side effects of Ipilimumab 50mg Injection:

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.

Common side effects of Ipilimumab:

  • Fatigue
  • Diarrhea
  • Nausea and vomiting
  • Skin rash and itching
  • Fever
  • Loss of appetite
  • Headache
  • Hormone gland problems

Machanism Of Action Of Ipilimumab 50mg Injection:

Ipilimumab Injection is a monoclonal antibody that blocks a protein called CTLA-4 on T-cells. CTLA-4 normally acts as a brake that limits T-cell activity. By blocking it, Ipilimumab releases this brake, allowing T-cells to become more active and multiply, mounting a stronger immune attack against cancer cells.

Contact Us

Info Table
Packaging Size 10ml Vial
Composition IPILIMUMAB-50MG/10ML
Manufacturer/Marketer BRISTOL MYERS SQUIBB
Consume Type Parenteral
Treatment Metastatic Melanoma, Renal Cell Carcinoma
Prescription/Non prescription Prescription
Form Injection (Concentrate for Solution for Infusion)
Country of Origin Imported
Vendor Info
Benefits
Reviews

Description

Introduction Of Ipilimumab 50mg Injection:

Ipilimumab 50mg Injection is an immune checkpoint inhibitor used mainly in the treatment of advanced or metastatic melanoma, and in certain other cancers including renal cell carcinoma and non-small cell lung cancer.

Ipilimumab 50mg Injection is administered only by a trained healthcare professional as an intravenous infusion, usually over 90 minutes. Your doctor will decide the dose and schedule, often given once every 3 weeks for a set number of doses, based on your condition and treatment plan. It should never be self-administered.

Because this medicine works by activating the immune system, it can sometimes cause the immune system to attack healthy tissues as well. Diarrhea, skin rash, and fatigue are among the most common effects. Your doctor will monitor you closely for signs of inflammation in the intestines, liver, skin, or hormone glands. Inform your doctor immediately if you notice severe abdominal pain, persistent diarrhea, yellowing of the skin or eyes, or unusual fatigue.

Uses Of Ipilimumab 50mg Injection:

  • Advanced/Metastatic Melanoma
  • Advanced Renal Cell Carcinoma
  • Certain other advanced cancers (in combination regimens), including lung and colorectal cancer

Benefits Of Ipilimumab 50mg Injection:

1. Advanced Melanoma

Melanoma is a serious form of skin cancer that can spread to other parts of the body. Ipilimumab 50mg Injection works by releasing a natural brake on the immune system, allowing T-cells to recognize and attack melanoma cells more effectively, which can improve survival in advanced disease.

2. Advanced Renal Cell Carcinoma and Other Cancers

In advanced kidney cancer and certain other cancers, Ipilimumab 50mg Injection, often combined with other immunotherapy drugs, helps stimulate a stronger immune response against tumor cells, supporting disease control.

Side effects of Ipilimumab 50mg Injection:

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.

Common side effects of Ipilimumab:

  • Fatigue
  • Diarrhea
  • Nausea and vomiting
  • Skin rash and itching
  • Fever
  • Loss of appetite
  • Headache
  • Hormone gland problems

Machanism Of Action Of Ipilimumab 50mg Injection:

Ipilimumab Injection is a monoclonal antibody that blocks a protein called CTLA-4 on T-cells. CTLA-4 normally acts as a brake that limits T-cell activity. By blocking it, Ipilimumab releases this brake, allowing T-cells to become more active and multiply, mounting a stronger immune attack against cancer cells.

Contact Us

Reviews

There are no reviews yet.

Be the first to review “Yervoi Ipilimumab 50mg / 10ml Injection”

Your email address will not be published. Required fields are marked *

Frequently Asked Questions

From sourcing to delivery, we ensure reliability at every step. Our operations follow strict quality and regulatory standards.

What is Ipilimumab 50mg Injection used for?
Ipilimumab 50mg/10ml Injection (Yervoi) is a monoclonal antibody used to treat metastatic melanoma, a type of skin cancer that has spread to other parts of the body.
It blocks CTLA-4, an immune checkpoint protein that normally suppresses the immune system, which helps activate T-cells to recognize and attack cancer cells.
Clinical trials have shown it can improve overall survival in advanced melanoma patients, with some experiencing durable, long-lasting responses to treatment.
It may be used alone or combined with other immunotherapies, such as nivolumab or pembrolizumab, to further enhance the immune response against cancer cells.
It can cause immune-related side effects, which are generally manageable with close medical monitoring and, if needed, corticosteroids or other immunosuppressive medications.
It works by helping the immune system recognize and attack cancer cells, and is used to treat melanoma and other advanced cancers. See Drugs.com for more.

Related products